We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · August 12, 2022

Safety and Efficacy of Bevacizumab in Patients Undergoing High-Risk Corneal Transplantation



Additional Info

Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control Trial
Ophthalmology 2022 Aug 01;129(8)865-879, TH Dohlman, M McSoley, F Amparo, T Carreno-Galeano, M Wang, M Dastjerdi, RB Singh, G Coco, A Di Zazzo, H Shikari, U Saboo, K Sippel, J Ciralsky, SH Yoo, M Sticca, TH Wakamatsu, S Murthy, P Hamrah, U Jurkunas, JB Ciolino, JAP Gomes, VL Perez, J Yin, R Dana

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading